California Tightens Oversight of Drug Costs and Private Equity in Healthcare
California Governor Gavin Newsom recently signed two bills into law aimed at increasing transparency and control over rising healthcare costs. These measures target pharmacy benefit managers (PBMs) and private equity firms – both increasingly scrutinized for their roles in the healthcare landscape. This article breaks down what these changes mean for you, the patient, and the future of healthcare access and affordability in the state.
New Law Challenges PBM Practices
Senate Bill 41 (SB 41) seeks to regulate how pbms operate, specifically regarding drug pricing and transparency. PBMs act as intermediaries between drug manufacturers, insurance companies, and pharmacies, negotiating drug prices and managing prescription benefits.
However,the law has faced immediate legal challenges. A judge blocked SB 41 from taking effect in July,following pushback from the PBM industry. The core of the dispute centers around requirements for PBMs to disclose more information about their pricing practices and relationships with pharmacies.
The Pharmaceutical Care Management Association (PCMA), a PBM lobbying group, promptly blamed drug manufacturers, stating the bill “will not lower drug costs for Californians.” They argue it’s a distraction from the high list prices set by pharmaceutical companies.
Increased Scrutiny of Private Equity
Alongside the PBM regulations, Newsom signed Assembly Bill 1415 (AB 1415), focusing on the growing influence of private equity in healthcare. This new law requires private equity firms to notify the state’s Office of Health Care Affordability (OHCA) before completing major healthcare transactions like mergers and acquisitions.
currently, the OHCA can only review these transactions, not veto them. This follows the recent enactment of SB 351, which prevents private equity firms from interfering with medical decision-making.
here’s what you need to no about the shift:
* Rapid Growth: Private equity investment in healthcare has “quintupled over the past decade,” according to state Senator Christopher Cabaldon.
* Increased Oversight: AB 1415 gives the OHCA the authority to monitor these financial dealings.
* Patient Protection: The goal is to protect patients from rising costs and reduced access to care.
* Transparency: Californians deserve a clear understanding of how billions of dollars are being invested in their healthcare system.
Assembly member Mia Bonta emphasized that the law will help ensure the OHCA can “protect patients from rising costs and reduced access to care.”
A History of Vetoes and evolving Policy
This isn’t the first attempt to regulate private equity in california healthcare. Last year, Newsom vetoed a bill that would have given the state’s attorney general the power to block healthcare transactions. He reasoned that the OHCA was better positioned to analyze the potential impact on market competition and affordability targets.
California’s increased focus on private equity comes as the state experiences a significant surge in investment. A report from the California Health Care Foundation reveals that private equity-backed acquisitions accounted for roughly one-third of all healthcare deals in the state between 2019 and 2023.
What Does This mean for You?
These new laws represent a significant step toward greater transparency and accountability in California’s healthcare system. While the immediate impact of SB 41 is uncertain due to the legal challenge, the increased scrutiny of both PBMs and private equity firms signals a commitment to addressing rising healthcare costs and protecting patient access.
You can expect:
* More information: Increased transparency regarding drug pricing and financial transactions.
* Potential cost savings: While not guaranteed, the regulations aim to create a more competitive and affordable healthcare market.
* Stronger patient protections: Safeguards against potential conflicts of interest and inappropriate interference in medical decisions.
Resources:
* Judge halts Arkansas PBM pharmacy law
* California latest state to enact tougher restrictions on private equity in healthcare
*[SenatorCab[SenatorCab[SenatorCab[SenatorCab
Worth a look